Securities Class Action

No Litigation found for Lantern Pharma Inc.

Material Events

Critical Governance & Disclosure

2

Board, Voting & Shareholder Rights

1

Capital Structure & Financial Risk

2

Disclosure & Communications

23

SEC Filings

DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-11-20

View DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material on SEC.gov
8-K

Current report

2026-11-18

View 8-K Current report on SEC.gov
DEF 14A

Other definitive proxy statements

2026-10-19

View DEF 14A Other definitive proxy statements on SEC.gov
PRE 14A

Other preliminary proxy statements

2026-10-08

View PRE 14A Other preliminary proxy statements on SEC.gov
8-K

Current report

2026-10-01

View 8-K Current report on SEC.gov

Insider Transaction

No Insider Transactions found for Lantern Pharma Inc.